Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

160 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
High resection rates of colorectal liver metastases after standardized follow-up and multimodal management: an outcome study within the COLOFOL trial.
Scherman P, Hansdotter P, Holmberg E, Viborg Mortensen F, Petersen SH, Rizell M, Naredi P, Syk I; COLOFOL study group. Scherman P, et al. Among authors: naredi p. HPB (Oxford). 2023 Jul;25(7):766-774. doi: 10.1016/j.hpb.2023.03.003. Epub 2023 Mar 9. HPB (Oxford). 2023. PMID: 36967324 Free article. Clinical Trial.
Intratumoural expression of dihydropyrimidine dehydrogenase is an independent prognostic factor in resected pancreatic ductal adenocarcinoma treated with adjuvant gemcitabine.
Blomstrand H, Bodarve M, Groth F, Naredi P, Sund M, Vilhav C, Green H, Björnsson B, Öhlund D, Lindblad S, Franklin O, Elander NO. Blomstrand H, et al. Among authors: naredi p. Oncol Lett. 2024 Dec 10;29(2):99. doi: 10.3892/ol.2024.14845. eCollection 2025 Feb. Oncol Lett. 2024. PMID: 39703529 Free PMC article.
Adjunct mucin biomarkers MUC2+MUC5AC and MUC5AC+PSCA in a clinical setting identify and may improve correct selection of high-risk pancreatic lesions for surgery.
Philipson E, Jabbar K, Bratlie SO, Hansson G, Persson J, Vilhav C, Wennerblom J, Sadik R, Naredi P, Bourghardt Fagman J, Engström C. Philipson E, et al. Among authors: naredi p. HPB (Oxford). 2024 Nov 2:S1365-182X(24)02388-8. doi: 10.1016/j.hpb.2024.10.018. Online ahead of print. HPB (Oxford). 2024. PMID: 39562183 Free article.
European Groundshot-addressing Europe's cancer research challenges: a Lancet Oncology Commission.
Lawler M, Davies L, Oberst S, Oliver K, Eggermont A, Schmutz A, La Vecchia C, Allemani C, Lievens Y, Naredi P, Cufer T, Aggarwal A, Aapro M, Apostolidis K, Baird AM, Cardoso F, Charalambous A, Coleman MP, Costa A, Crul M, Dégi CL, Di Nicolantonio F, Erdem S, Geanta M, Geissler J, Jassem J, Jagielska B, Jonsson B, Kelly D, Kelm O, Kolarova T, Kutluk T, Lewison G, Meunier F, Pelouchova J, Philip T, Price R, Rau B, Rubio IT, Selby P, Južnič Sotlar M, Spurrier-Bernard G, van Hoeve JC, Vrdoljak E, Westerhuis W, Wojciechowska U, Sullivan R. Lawler M, et al. Among authors: naredi p. Lancet Oncol. 2023 Jan;24(1):e11-e56. doi: 10.1016/S1470-2045(22)00540-X. Epub 2022 Nov 16. Lancet Oncol. 2023. PMID: 36400101 Free article. Review.
Impact of Surgery-Induced Myeloid-derived Suppressor Cells and the NOX2/ROS Axis on Postoperative Survival in Human Pancreatic Cancer.
Grauers Wiktorin H, Aydin E, Kiffin R, Vilhav C, Bourghardt Fagman J, Kaya M, Paul S, Westman B, Bratlie SO, Naredi P, Hellstrand K, Martner A. Grauers Wiktorin H, et al. Among authors: naredi p. Cancer Res Commun. 2024 Apr 25;4(4):1135-1149. doi: 10.1158/2767-9764.CRC-23-0447. Cancer Res Commun. 2024. PMID: 38598844 Free PMC article.
160 results